Biotech Bonanza: Ligand Takes out Pharmacopeia (LGND, PCOP)

Health and Healthcare

Published: September 24, 2008 5:52 pm

This might not be the biggest of biotech mergers out there, but deals are continuing in the bio-space. Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has entered into a definitive merger agreement to acquire Pharmacopeia (NASDAQ: PCOP) in a deal valued up to $70 million.

The transaction is structured as a stock-for-stock exchange for thefirst part of the deal and in the second part there is an addedkicker. Pharmacopeia stockholders will be entitled to a ContingentValue Right which will entitle shareholders under certain circumstancesto receive an aggregate cash payment of $15 million for allPharmacopeia stockholders.

Ligand will issue approximately 17.5 million shares, subject toadjustment for Pharmacopeia options at closing, or 0.58 shares for eachoutstanding Pharmacopeia share. This will give Ligand 84% of thecombined company.

This exchange ratio is based on closing prices of Ligand shares between$3.00 and $3.75 for a period prior to the closing date and based onLigand’s closing price on September 24, 2008 of $3.12 implies apurchase price of $1.81 per common share of Pharmacopeia. This excludes a potential for approximately $0.50 per share or anaggregate of $15 million related to the Contingent value right. Hereare the other price contingencies:

At prices between $3.75 and $4.50, value is fixed at $66 million.
At prices above $4.50, the exchange ratio is fixed at 0.49.
At prices below $3.00, value is fixed at $52.8 million, including some cash contribution at prices below $2.93 and above $2.38.
Below $2.38 the consideration is fixed at 0.60 shares and $10 million in cash in the aggregate.
At prices equal or less than $1.65 Pharmacopeia has the right to terminate the agreement.

Shareholders could also receive an aggregate $15 million cash paymentas the terms of the Contingent Value Right if Ligand enters into alicense, sale, development, marketing or option agreement with respectto its DARA program by December 31, 2011. Please note, the CVRs willnot be transferable.

Jon C. Ogg
September 24, 2008

The Average American Has No Idea How Much Money You Can Make Today ^(Sponsor)

The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.

But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.

Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

¹https://www.fdic.gov/national-rates-and-rate-caps